Company intelligence / Profile preview
Horus Pharma
- Ownership
- Private
- Development stage
- Other
Overview
Horus Pharma is a leading independent French pharmaceutical company specializing in preservative-free ophthalmology products, with a portfolio of 60+ innovative solutions including prescription medicines, medical devices, and food supplements. The company has European marketing authorizations for its drugs and distributes its products in over 30 countries. Its lead product includes fluocinolone acetonide for diabetic macular oedema, which has reached the NDA/BLA stage.
- Therapeutic areas
- Ophthalmology
- Modalities
- Small moleculeMedical deviceFood supplement (nutraceuticals)
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Horus Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Horus Pharma.